← Back to Vaccine Database

mRNA-1273.529-Booster

RNA based vaccine · VDDBV0503

Target & Classification

SARS-CoV-2SARS-CoV-2
RNA based vaccine
COVID-19
Phase 3

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT05249829 Phase 3COVID-19